مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

787
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

COMPARISON OF TETROPIUM AND β2 AGONIST THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS

Pages

  485-500

Abstract

 Introduction: The long-acting anticholinergic TIOTROPIUM, which used in the treatment of patients with CHRONIC OBSTRUCTIVE PULMONARY DISEASE, prescribed once a day, unlike other BRONCHODILATORS that used several times a day for patients. The study was a systematic review that examined the effectiveness and SAFETY of b2 Agonists and TIOTROPIUM in the patients with CHRONIC OBSTRUCTIVE PULMONARY DISEASE.Methods: RCT (randomized controlled trials) and CCT (controlled clinical trials) studies that compared TIOTROPIUM and b2 agonists extracted from PubMed, SCOPUS, Ovid Medline and Cochran databases regardless of the time limitation were studied. Only studies were reviewed that were in English. In total, eight articles have been evaluated. Meta-analysis was performed using STATA software Conclusions: The results showed less EFFICACY based on two outcomes include FEV1 (Forced expiratory volume in 1 second) and FEV1 / FVC, and a little higher EFFICACY based on other outcomes such as (FVC). In terms of SAFETY it can be said, the overall incidence of adverse events in both treatments was the same and it has been reported from moderate to severe according to the findings. Mostly, serious side effects were in form of intensifying attacks. The percentage of patients with severe complications in the TIOTROPIUM group were less than Salmeterol group (0.9 vs.3.1%, p=0.04). In addition, a limited number of deaths observed in both treatment which were often unrelated to the applied treatment.Conclusion: The results showed that TIOTROPIUM treatment compared to β2 agonists was superior to SAFETY. On the other hand, it showed less EFFICACY in the EFFICACY outcomes (FEV1 and FEV1 / FVC), and in the case of (FVC) effectiveness at a higher rate.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    DEHGHAN, HAMIDREZA, YAZDANI SHORMASTI, NEDA, & REZAEI, NIMA. (2017). COMPARISON OF TETROPIUM AND β2 AGONIST THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS. JOURNAL OF SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES, 25(6 ), 485-500. SID. https://sid.ir/paper/36749/en

    Vancouver: Copy

    DEHGHAN HAMIDREZA, YAZDANI SHORMASTI NEDA, REZAEI NIMA. COMPARISON OF TETROPIUM AND β2 AGONIST THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS. JOURNAL OF SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2017;25(6 ):485-500. Available from: https://sid.ir/paper/36749/en

    IEEE: Copy

    HAMIDREZA DEHGHAN, NEDA YAZDANI SHORMASTI, and NIMA REZAEI, “COMPARISON OF TETROPIUM AND β2 AGONIST THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS,” JOURNAL OF SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES, vol. 25, no. 6 , pp. 485–500, 2017, [Online]. Available: https://sid.ir/paper/36749/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button